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MRP8 and MRP14 are members of the S100 family of calcium-binding proteins which play an
important role during calcium-induced activation of phagocytes. Both proteins form nonco-
valently associated complexes as a prerequisite for biological functions. The exact stoichio-
metric composition of these complexes, however, has not been completely clarified yet. In the
present study we show for the first time by ultraviolet matrix-assisted laser desorption/
ionization mass spectrometry (UV-MALDI-MS) the calcium-induced formation of nonco-
valently associated (MRP8/MRP14)2 tetramers. Furthermore, we could determine posttrans-
lational modifications of MRP8 and MRP14, the stoichiometric proportion of the two known
MRP14 isoforms in the complexes as well as the number of calcium ions bound to the single
MRP8 and MRP14 monomers and tetramers. MRP14 showed a higher affinity for calcium than
MRP8. Upon complex formation the calcium binding increased to maximal saturation of the
known EF hands in the complexed forms. Calcium-induced stabilization of the MRP8/MRP14
complexes was confirmed by DSC studies. Our results extend scope and application of
UV-MALDI-MS by allowing identification of noncovalent protein complexes, the identification
of minor alterations of subunits in such complexes as well as the determination of bound
calcium ions. (J Am Soc Mass Spectrom 1999, 10, 1124–1130) © 1999 American Society for
Mass Spectrometry
The S100-protein family has grown to one of thelargest subfamilies of calcium-binding proteins.Members of this family are characterized by two
calcium-binding sites of the EF-hand type, a relatively
low molecular weight, and a tissue specific expression
pattern. S100 proteins have been shown to be involved
in various cellular functions, e.g., cell cycle progression,
cellular differentiation, or modulation of cytoskeleton–
membrane interactions [1–3]. The macrophage migra-
tion inhibitory factor related proteins MRP8 (S100A8)
and MRP14 (S100A9) are two members of this protein
family which are expressed in large quantities in mono-
cytes and granulocytes but are absent in lymphocytes
[4–7]. Expression of MRP8 and MRP14 in monocytes is
restricted to early stages of differentiation [4, 6, 8] and is
completely down regulated in mature macrophages [9].
During the early stages of differentiation both proteins
represent about 40% of the total calcium-binding capac-
ity in monocytes [10]. MRP8 and MRP14 form nonco-
valently associated complexes in a calcium-dependent
manner. These protein complexes translocate from the
cytosol to membrane structures and intermediate fila-
ments in a calcium dependent fashion, which was
shown to correlate with phagocytic activation [11–13].
Several biological functions of MRP8 and MRP14 have
been ascribed to either the single monomers or different
complexes of these proteins [14–16]. Furthermore, com-
plex formation of MRP8 and MRP14 in vivo has been
shown to characterize distinct monocytic subpopula-
tions under different inflammatory conditions [17, 18].
Presently, it is difficult to determine the composition
of the biologically active complexes due to principal
limitations of the classical analytical techniques lacking
the desired accuracy (gel filtration), often destroying
noncovalent interactions (PAGE) or producing artificial
results (cross-linking). The interpretation of light scat-
tering experiments requires knowledge of the shape of
the protein. Analytical ultracentrifugation is presently
considered to be the method of choice, but also gives
only limited information about the exact complex com-
position. This situation is further complicated by the
Address reprint requests to Dr. Thomas Vogl, Institute of Experimental
Dermatology, University of Mu¨nster, von-Esmarchstraße 56, D-48149 Mu¨n-
ster, Germany. E-mail: vogl@uni-muenster.de
© 1999 American Society for Mass Spectrometry. Published by Elsevier Science Inc. Received March 2, 1999
1044-0305/99/$20.00 Revised June 2, 1999
PII S1044-0305(99)00085-9 Accepted June 8, 1999
fact, that some of these experiments were done in the
presence of calcium and some without it. Consequently,
there exist many contradictory reports about the exact
MRP8/MRP14 complex structure. MRP8 and MRP14
monomers, MRP8/MRP14 heterodimers, (MRP8)2 and
(MRP14)2 homodimers, (MRP8)2/(MRP14) and
(MRP8)/(MRP14)2 trimers, as well as (MRP8/MRP14)2
tetramers have been described depending on the ana-
lytical method used [14, 19–21]. In addition, a ho-
modimer of murine MRP8 has been detected by elec-
trospray ionization mass spectrometry (ESI-MS) [22].
Such homodimers have not been found in murine
myelomonocytic cells by cross-linking techniques [23].
Further confusion comes from the fact that MRP14
exists in two isoforms, the smaller of which is MRP14*
supposed to start at the second methionine at position
five and therefore lacking four amino acids at the
N-terminus [14, 20].
It has recently been shown that ultraviolet matrix-
assisted laser desorption/ionization mass spectrometry
(UV-MALDI-MS) can be used for such analyses, pro-
vided, that special precautions are taken in preparing
the samples, using suitable matrices, and collecting the
spectra. Specific complex formation of protein–protein
interactions analyzed by MALDI-MS was first reported
by Karas et al. [24, 25]. In summary, only a limited
number of matrix/laser wavelengths combinations will
preserve complexes throughout the whole procedure
and, most importantly, only spectra recorded from the
top layer of the samples show pronounced signals of
the complexes under such conditions. The latter obser-
vation, termed “first shot phenomenon,” was reported
by Rosinke et al. [26] and Cohen et al. [27] as well as
Moniatte et al. [28] for the homooligomeric quaternary
structure of a number of hydrophilic and hydrophobic
proteins. The main caveat in applying MALDI-MS for
the determination of noncovalently formed complexes
is the well known tendency of MALDI spectra to exhibit
signals of nonspecific homo- as well as heterooligomers
of proteins, believed to be formed in the gas phase after
desorption [29]. The singly charged monomer typically
represents the base peak with the signals of nonspecific
oligomers decreasing approximately exponentially in
intensity with increasing order of the oligomerization.
As a rule oligomer signals in MALDI-MS can, therefore,
only be interpreted as being specific, if their signals
exceed those of monomeric species, as will be shown in
this study.
Specific protein/metal–ion interaction studies had
been performed by Woods et al. [30]. Zinc-finger pep-
tides were synthesized and measured in a a-cyano-4-
hydroxy cinnamic acid matrix by UV-MALDI-MS for
different Zn21-ion concentrations. Woods et al. do not
describe a “first shot phenomenon” for the peptide/
metal–ion interaction under their experimental condi-
tions; the small complex signals are observed indepen-
dent of the depth into the sample. In the present study
we describe the UV-MALDI-MS analysis of calcium-
dependent formation of (MRP8/MRP14)2 tetramers. In
addition, this method allows the determination of post-
translational modifications of MRP14, MRP14 isoform
patterns in the complex as well as the number of
calcium ions bound to the monomers and the complex.
Experimental Procedures
Purification of MRP8 and MRP14 from
Granulocytes
Granulocytes were prepared from human buffy coats
by Ficoll-Paque (Pharmacia, Freiburg, Germany) cen-
trifugation [31, 32]. MRP8 and MRP14 were purified as
described earlier [33]. Briefly, granulocytes were soni-
cated and the majority of proteins was precipitated by
addition of 70% ammonium sulfate. The main fraction
of MRP8 and MRP14 remained in the supernatant. After
dialysis anion exchange chromatography was carried
out using a Kontron FPLC on a equilibrated Pharmacia
Q Sepharose column model 26/10. The protein was
eluted with a linear gradient from 0 to 1 M NaCl. The
main fraction of MRP8 and MRP14 (purity of .98%)
was eluted at NaCl concentrations of about 175 mM. A
single contamination could be detected by silver stain-
ing which was identified as neutrophil elastase inhibi-
tor by protein sequencing. The identity of MRP8 and
MRP14 was ascertained by polyacrylamide gel electro-
phoresis (SDS-PAGE), amino acid sequencing, western
blotting, and immuno-staining with specific antisera
against the two proteins.
Protein concentrations were determined by UV ab-
sorption using an absorption coefficient of « (1%, 1
cm) 5 7.5 mL mg21 at 280 nm for the MRP8/MRP14
complex [34–36]. Before each measurement, all samples
were routinely dialyzed against 20 mM TRIS, pH 7.5 in
the absence (for DSC measurements) and presence (for
MALDI-MS) of 1 mM DTT and different concentrations
of calcium ions. To avoid possible oxidation reactions,
i.e., formation of disulfide bridges between cys3 of
MRP14 and cys42 of MRP8, reducing conditions (1 mM
DTT) were maintained and/or all buffers were exten-
sively saturated with nitrogen following degassing
prior to all measurements.
MALDI-MS Instrumental
The principle of MALDI is described in the literature
[37]. In our investigations a home-built time-of-flight
system equipped with a linear and a reflectron port was
used. A frequency-tripled Nd-YAG-laser (JK-Laser,
Warwickshire, UK) at 355 nm and a pulse duration of 15
ns or a N2 laser (Laser Science, Newton, USA; 337 nm,
3 ns), respectively, served for the desorption/ionization
of molecules. A conventional secondary electron multi-
plier (EMI 9643, Electron Tube, UK) plus conversion
dynode (R2362, Hamamatsu, Japan) in front of it was
used as detector system. A transient recorder (LeCroy
9354, LeCroy, Chestnut Ridge) and a PC were used for
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data accumulation and data processing. Ions were ac-
celerated to energies of 20 keV (linear mode) and 16 keV
(reflectron mode) and post accelerated in front of the
detector to total ion energies of 38 keV (linear mode)
and 34 keV (reflectron mode). The instrument allowed
delayed ion extraction (DE). However, neither did DE
influence the intensity of the complex signals nor their
mass resolution.
MALDI-MS Sample Preparation
The 2,6-dihydroxyacetophenone (2,6-DHAP, Aldrich,
Steinheim, Germany) matrix was prepared as a satu-
rated solution in a mixture of acetonitrile/water (1/3;
v/v). The 6-aza-thiothymine (6-ATT, Sigma, Deisen-
hofen, Germany) matrix was dissolved in water to a
concentration of 10 g L21. The super-DHB matrix was
prepared by mixing an aqueous 15 g L21 solution of
2,5-dihydroxybenzoic acid with a 15 g L21 ethanol
solution of 2-hydroxy-5-methoxy benzoic acid (both
Aldrich, Steinheim, Germany), at a ratio of 9/1 (v/v)
[27, 38]. The actual MALDI samples were prepared
directly on the stainless steel MALDI target by mixing
0.5 mL of the protein solution (42 mM) containing equal
amounts of MRP8 and MRP14 with 0.5 mL of either
doubly distilled water or CaCl2 solutions of 50, 5, 0.5,
and 0.05 mM concentration and 2.5 mL of matrix solu-
tion yielding a final protein concentration of 6 mM. The
calcium solutions provided to 300:1, 30:1, 3:1, and 0.3:1
Ca ions per binding site, respectively. All samples were
allowed to dry in a stream of cold air. Incubation for
times longer than the few minutes of on-target sample
preparation at room temperature did not change the
results.
Differential Scanning Calorimetry Measurements
(DSC)
The temperature dependence of the apparent molar
heat capacity was determined using either a Privalov-
type DASM4 adiabatic differential scanning microcalo-
rimeter or a NANO-DSC (CSC, Applied Thermody-
namics, Utah, USA). Data were collected automatically
by a PC and a 6 digit Keithley 192 DMM Voltmeter
(Keithley) serving as analog to digital converter. Appar-
ent molar heat capacity (Cp) and temperature were
registered in 0.1 °C steps. The heating rate employed
was 2 °C min21. Each protein run was preceded by a
calibration run with equilibrium-buffer filled cells to
establish the baseline. At neutral pH values all transi-
tions are irreversible as indicated by the absence of a
transition after reheating of the same sample. DSC data
were, therefore, only used to compare the stability of
MRP8/MRP14 in the presence (2 mM) and absence of
calcium ions. The concentration of the protein sample
was 42 mM.
Results and Discussion
Analysis of Complex Formation by UV-MALDI-
MS
In order to investigate whether calcium binding by
MRP8 and MRP14 induces formation of complexes,
calcium ions were added to these proteins and complex
association was analyzed by UV-MALDI-MS. 2,6-
DHAP was used as matrix. The results are shown in
Figure 1. The molecular masses derived from these
measurements are summarized in Table 1.
In the absence of calcium ions no signals of specific
complexes are observed, not even for first exposures of
a given spot. Signals corresponding to the monomers of
MRP8, MRP14*, and MRP14 are the most intense sig-
nals in the spectrum (Figure 1a; Table 1). The molecular
mass of MRP8 was determined to 10842 6 3 Da in fairly
good agreement with the calculated mass of 10,835 Da
(M 1 H)1. Preliminary results using electrospray-ion-
ization-quadrupole-time-of-flight mass spectrometry
(ESI-Q-TOF-MS) revealed that MRP8 is partly oxidized
(plus 16 Da or plus 32 Da)—probably on the N-terminal
methionine—which explains the slight shift to higher
molecular masses determined by MALDI-MS. The peak
for MRP14 at 13,157 6 3 Da is in agreement with the
expected mass, assuming a missing N-terminal methi-
onine and an acetylation of the threonine at the remain-
ing N-terminus. The peak at 12,693 6 3 Da represents
MRP14* and results from a translation starting at amino
acid 5, removal of the methionine and acetylation of
amino acid 6 (serine) giving a calculated mass for
(MRP14* 1 H)1 of 12,691 Da. A lack of the first four
amino acids had been proposed earlier because of the
lower molecular weight of MRP14* on SDS-PAGE and
the absence of the single cysteine of the molecule [14,
20]. For both, MRP14 and MRP14* oxidations were
observed under ESI-MS, however, to a much lesser
extent than for MRP8 (data not shown).
Also present in the spectrum (Figure 1a) is a minor
peak of the impurity elastase inhibitor. All other minor
peaks can be assigned to various nonspecific oligomers
of the proteins present in the sample such as the dimers
of MRP14 and MRP14* near mass 25 kDa. It is impor-
tant to note that all these signals are rather weak
compared to the sum signals of the monomers they
result from. The peak areas of the MRP14 and MRP14*
monomer signals exceed those of their nonspecific
dimers by a factor of about 3 to 5, typical for MALDI
spectra under the conditions used. The absence of
intense signals corresponding to heterodimers in the
calcium-free sample excludes disulfide bridge forma-
tion of MRP8 and MRP14 under these conditions. In
contrast to the data shown above, in the presence of
calcium ions the overwhelming base peak in first shot
spectra corresponds to a tetramer (48 kDa), composed
of two molecules of MRP8 and two molecules of
MRP14/MRP14*, respectively (Figure 1b; Table 1). Suc-
cessive spectra obtained from a given spot of such
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calcium containing samples resemble that of Figure 1a.
This “first shot phenomenon” agrees with results re-
ported earlier on the analysis of specific noncovalent
protein–protein interactions [26, 27]. In addition, the
calcium dependency of complex formation also indi-
cates specificity of the findings. Minor signals of the
MRP8, MRP14*, and MRP14 monomers are also ob-
served under these conditions. It is interesting to note
that the relative signal intensities of the MRP8 mono-
mer to the MRP14/14* monomers are reverted in the
presence of calcium, most likely indicating a calcium-
induced conformational change of either one or both
proteins, thereby changing the detection sensitivity in
the MALDI analysis.
The detection of MRP8/MRP14 complexes depends
on the matrix used. 6-ATT-matrices—known to allow
for the detection of noncovalent protein complexes
[27]—also resulted in the detection of the (MRP8/
MRP14)2 tetramer in the presence of calcium ions.
However, the reproducibility of sample preparation
was poorer and the tetramer was less frequently de-
tected compared to preparations with the 2,6-DHAP
matrix. Also the number of attached calcium ions was
much less reproducible with 6-ATT matrix. Super-DHB
matrix allowed neither the detection of complex nor of
calcium ions attached to the subunits; this failure to
detect noncovalent protein/protein formation is consis-
tent with results reported earlier [27]. The formation of
disulfide bridges cannot have caused the tetramer for-
mation, because all experiments were performed under
Figure 1. UV-MALDI-reflectron-TOF-mass spectra of MRP8/MRP14 complex applying different
calcium concentrations under reducing conditions (1 mM DTT). Matrix: 2,6-dihydroxy-acetophenone.
Sum of 10 single shot spectra. M: monomer; T: tetramer; E. I.: elastase inhibitor, about 43 kDa. (a)
Without calcium, no complex formation. First and following shots of a given spot show the same mass
spectral information. (b) With calcium, formation of noncovalently associated tetramers. First shots of
given spots are accumulated only. 30 calcium ions per binding site. (c) Inset of (b). Mass range
15,000–27,000 Da. (d) Inset of (b). Mass range 45,000–51,000 Da. The singly, doubly, and triply charged
tetramers show the same signal pattern. Both isoforms of MRP14 are equivalent in forming tetramers
with MRP8.
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reducing conditions. Furthermore, tetramers containing
MRP14*, lacking the single cysteine residue, were also
detected and no measurable signal of the tetramers was
detected in the absence of calcium (Figure 1a) under
otherwise identical conditions. A second prominent
group of signals is detected at a molecular mass of
around 24 kDa. This peak could theoretically represent
doubly charged tetramers (T21) or singly charged
MRP8/MRP14 heterodimers. However, at close look
this peak reveals an identical triplet structure as that of
the singly charged tetramer (T1) at 48 kDa. This is
shown in expanded details c and d of the spectrum of
Fig. 1b. For instance the center peak at 23,905 Da (see
Table 1) cannot be explained by either a MRP8/MRP14
or MRP8/MRP14* heterodimer. It can only represent
the doubly charged tetramer [(MRP8/MRP14* 1
MRP8/MRP14) 1 8 Ca]21. The peak at m/z 16,000
strongly supports this conclusion; it can only be as-
signed to the triply charged tetramer (T31), because no
other oligomer matches this mass. The quadruply
charged tetramer appears as a small peak in between
those of the monomeric species. A dimer of the singly
charged tetramer (formally an octamer) appears at a
mass of about 96 kDa. The ratio of its peak area to that
of the tetramer is about equal to that of the nonspecific
dimers in Figure 1a to that of their monomers. The
dimer of the tetramer is, therefore, considered to be
nonspecific as well. All other additional minor peaks
can be assigned to nonspecific oligomers of the species,
present in the sample and to the elastase inhibitor
impurity.
We, therefore, conclude, that the observed calcium-
induced tetramers of MRP8 and MRP14/MRP14*, i.e.,
(MRP8/MRP14*)2, (MRP8/MRP14*)(MRP8/MRP14),
and (MRP8/MRP14)2 are the dominant species present
in the in vitro assay and most probably represent the
biological relevant complexes of these proteins. Earlier
reports of different homodimers and trimers of MRP8
and MRP14 seem to be artifacts due to inaccurate
determination of molecular weights by gel chromatog-
raphy [39, 40], conclusions drawn from nonstoichiomet-
ric analysis of isoform patterns [41], artificial formation
of disulfide bridges [14, 20], or incomplete stabilization
of complexes by cross-linking [14, 23].
Calcium-induced tetramer formation is observed at
relatively low calcium ion concentrations already.
While at a calcium concentration of 0.3 calcium ions per
binding site no specific complexes are observed, a
calcium concentration of 3 calcium ions per binding site
clearly induces a measurable tetramer formation (data
not shown). This effect is maximal at a calcium concen-
tration of 30 calcium ions per binding site (Figure 1b).
Further increase of the calcium ion concentration de-
graded the mass resolution as typically observed for
MALDI preparations with a high salt content.
Concomitant to tetramer formation the protein con-
formation is altered by calcium binding as indicated by
spectroscopic investigations. These structural changes
occur at physiological calcium concentrations (data not
shown). The results are in accordance with reports
published earlier, showing that EF-hand proteins un-
dergo calcium-induced conformational changes [42].
The molecular masses of the peaks in the presence of
calcium ions are always higher than the molecular
masses of the monomers or the theoretical oligomer
masses in the absence of calcium. This fact can be
explained by a stable binding of calcium ions to the
monomers and complexes. From these mass shifts the
average number of calcium ions, bound to the subunits
or the complexes, respectively, can be calculated (Table
1). In the monomeric state MRP14* (1.4 6 0.7 Ca21 per
monomer) and MRP14 (1.5 6 0.6 Ca21 per monomer)
have a higher affinity to calcium ions than MRP8 (0.8 6
0.3 Ca21 per monomer). This is in agreement with
earlier reports of a higher calcium binding capacity of
MRP14 compared to MRP8 as shown by calcium over-
lay assays [10, 43]. The number of calcium ions bound
to the tetramers was calculated from the difference of
the observed masses of the tetramers and the sum of the
theoretical calculated molecular masses of the mono-
Table 1. Masses of MRP8, MRP14*, and MRP14 ion in the absence and of their specific tetrameric complexes in the presence of
calciuma
Monomers1 Tetramers21 Tetramers1
MRP8 MRP14* MRP14 2 3 (8/14*)
[(8 1 14*)
(8 1 14)] 2 3 (8/14) 2 3 (8/14*)
[(8 1 14*)
(8 1 14)] 2 3 (8/14)
MAmino
acid
10,835 12,691 13,154 23,527 23,758 23,989 47,049 47,512 47,975
m/zwithout
Ca21
10,842 6 3 12,693 6 3 13,157 6 3 23,547 6 8
[(8 1 14*)]b
. . . 24,010 6 5
[(8 1 14)]b
. . . . . . . . .
m/zwith
Ca21
10,873 6 9 12,751 6 26 13,219 6 21 23,660 6 29 23,905 6 26 24,129 6 15 47,359 6 38 47,816 6 44 48,290 6 37
Ca21 ions
bound
0.8 6 0.3 1.4 6 0.7 1.5 6 0.5 8 6 1 8 6 1 8 6 1
aThe mass values of the various singly and doubly charged tetramers (T1, T21) have been corrected for mass shifts caused by the incomplete mass
resolution of the three neighboring peaks in the ensemble. A peak simulation program was used to generate the sum spectra and determine the peak
shifts.
bNonspecific MALDI-induced singly charged dimers in the absence of calcium determined from the spectrum of Figure 1a.
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meric components as listed in Table 1. Within the error
limits identical results were obtained by using the
experimentally determined molecular masses of the
monomers. The masses of the three isomeric tetramers
have been obtained by internal calibration and have
been corrected to account for the lack of full baseline
resolution. Interestingly, within the experimental accu-
racy of 61 Ca21 we found the maximum possible
number of calcium ions of eight bound to the tetramer
which indicates a cooperative effect of calcium binding.
The experiments reported in this paper for MALDI-MS
have meanwhile been repeated by ESI-MS. They essen-
tially confirmed, that a heterodimer of MRP8/
MRP14(MRP14*) is formed in solution with no calcium
present and strong heterotetramer in the presence of
calcium as reported here. The ESI-MS results will be
published in a separate paper [44].
Analysis of Complex Stability by Differential
Scanning Calorimetry
Figure 2 shows representative heat capacity curves for
thermal unfolding of MRP8/MRP14 (c 5 42 mM) in the
absence and presence of calcium ions (2.0 mM, i.e., 12
calcium ions per binding site). This value is close to the
optimal calcium value observed by MALDI-MS. Both
transitions are irreversible (data not shown). However,
a simple comparison of the curves is permissible be-
cause identical conditions such as heating rate and
sample preparation were applied. Addition of calcium
ions has a significant influence on MRP8/MRP14 com-
plex stability. During or after the thermal denaturation
the complex aggregates without thermal effect indi-
cated by the Cp curve after the transition. Addition of
calcium (12 calcium ions per binding site) to the sample
leads to a significant stabilization of the MRP8/MRP14
complex, which results in an increase in the transition
temperature of 113 °C (from 70.4 6 1.4 to 83.3 6
0.7 °C). This shift indicates induction of unusually
strong noncovalent interactions in the MRP8/MRP14
complex. Annexin V, e.g., another calcium-binding pro-
tein is stabilized by only 19 °C by increasing the
calcium concentration from 0 to 730 Ca ions per binding
site [45, 46]. This high thermal stabilization of the
complex induced by the binding of calcium is a reason-
able explanation for the stability of the tetrameric
complex of MRP8 and MRP14 during the MALDI
procedure. In the absence of calcium the heat capacity
curves indicate only a single transition for MRP8/
MRP14. This finding can be explained by the presence
of heterodimers which are not stable under MALDI
conditions. The existence of heterodimers in the absence
of calcium is in accordance with earlier reports by
Teigelkamp et al. [14] and Edgeworth et al. [20].
Conclusions
MRP8 and MRP14 represent the major calcium-binding
proteins in phagocytes. Several biological functions of
these proteins have been shown to depend on their state
of complex formation. Murao et al. demonstrated an
inhibitory effect of the complexes of MRP8/MRP14 on
the activity of casein kinase I and II, whereas the single
monomers had no effect at all [16]. Furthermore, single
MRP14 has been recently shown to increase the affinity
of the integrin receptor CD11b/CD18 on human neu-
trophils, an effect which is antagonized by complex-
ation of MRP14 with MRP8 [47]. The biological rele-
vance of these in vitro studies is supported by the
finding, that the presence or absence of MRP8/MRP14
complex formation in vivo, respectively, defines dis-
tinct phenotypes of monocytes, which characterize spe-
cific inflammatory reactions, e.g., acute versus chronic
allograft rejection [17].
The identification of noncovalently bound com-
plexes by MALDI-MS is still discussed controversially
in the literature. The following main arguments support
the assumption that a calcium-induced tetramer of
MRP8 and MRP14 is specific, whereas homodimers and
trimers do not seem to play a physiological role. First,
the tetramer signal is the base peak in the spectrum,
with only minor signals of monomeric species. Second,
the doubly charged tetramer is clearly visible in the
spectra as evidenced by the peak structure, resembling
that of the tetramer, rather than that of the dimers. The
observation of triply and quadruply charged tetramers
at masses which do not correspond to other oligomeric
species support this finding. Third, spectra with a signal
of the tetramer can only be obtained for first exposures
of a given sample location. Would the tetramers have
been MALDI induced, especially would they have been
formed in the gas phase from desorbed monomers or
Figure 2. Experimental heat capacity curves of unfolding of
MRP8/MRP14 in the absence of calcium ions (continuous line)
and in the presence of 2 mM calcium ions in the buffer (dashed
line). Heating rate: 2 °C min21. Protein concentration: 42 mM. Each
measurement was reproduced at least twice. Comparison of the
heat capacity curves show, that the complex unfolds at a transition
temperature, t1/2, which is essentially higher, (13 6 2) °C, than
the transition temperature of the heterodimer in the absence of
calcium.
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dimers, there would be no reason why this should be
limited to the first exposure and only in the presence of
calcium. This “first shot phenomenon” is explained by a
model, according to which noncovalently bound com-
plexes dissociate under the usual incorporation into
matrix crystals upon drying of the sample. Only those
complexes remain intact, which precipitate onto the
crystal surface during the very last phase of the sample
formation, most probably after all the organic solvent is
evaporated and only an aqueous phase remains [27].
Fourth and finally, the fact that the intensity of the
tetramer signal can be titrated by Ca21 addition also
supports the specificity of the complexes.
In addition, our data indicate that accuracy of mass
determination by UV-MALDI-MS allows an identifica-
tion of isoform patterns and the degree of calcium ion
binding to proteins and their noncovalently associated
complexes as well as the observation of cooperativity in
this binding. This advantage may be generally useful
for analysis of calcium dependent protein–protein in-
teractions.
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